Press releases

7
Nov 2025
21:30 E.S.T.

Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update

Read more
3
Nov 2025
14:15 E.S.T.

Cellectis to Present a Development Update for eti-cel at ASH 2025

Read more
31
Oct 2025
20:30 E.S.T.

Cellectis to Report Third Quarter Financial Results on November 7, 2025

Read more
16
Oct 2025
19:00 E.S.T.

Cellectis’ R&D Day Highlights Lasme-cel’s Potential to Address Significant Unmet Need for Patients with r/r B-ALL

Read more
16
Oct 2025
11:00 E.S.T.

Cellectis Hosts R&D Day Today Showcasing Pipeline Progress and Long-Term Value Drivers

Read more
7
Oct 2025
06:40 E.S.T.

Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress

Read more
4
Aug 2025
20:30 E.S.T.

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates

Read more
28
Jul 2025
20:30 E.S.T.

Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025

Read more
26
Jun 2025
20:30 E.S.T.

Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025

Read more
21
May 2025
20:30 E.S.T.

Cellectis’ Annual Shareholders General Meeting to be Held on June 26, 2025

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US